138 related articles for article (PubMed ID: 10440697)
1. Serotonergic blockade in the treatment of the cancer anorexia-cachexia syndrome.
Edelman MJ; Gandara DR; Meyers FJ; Ishii R; O'Mahony M; Uhrich M; Lauder I; Houston J; Gietzen DW
Cancer; 1999 Aug; 86(4):684-8. PubMed ID: 10440697
[TBL] [Abstract][Full Text] [Related]
2. Comparison of orally administered cannabis extract and delta-9-tetrahydrocannabinol in treating patients with cancer-related anorexia-cachexia syndrome: a multicenter, phase III, randomized, double-blind, placebo-controlled clinical trial from the Cannabis-In-Cachexia-Study-Group.
; Strasser F; Luftner D; Possinger K; Ernst G; Ruhstaller T; Meissner W; Ko YD; Schnelle M; Reif M; Cerny T
J Clin Oncol; 2006 Jul; 24(21):3394-400. PubMed ID: 16849753
[TBL] [Abstract][Full Text] [Related]
3. A placebo-controlled double blind trial of etanercept for the cancer anorexia/weight loss syndrome: results from N00C1 from the North Central Cancer Treatment Group.
Jatoi A; Dakhil SR; Nguyen PL; Sloan JA; Kugler JW; Rowland KM; Soori GS; Wender DB; Fitch TR; Novotny PJ; Loprinzi CL
Cancer; 2007 Sep; 110(6):1396-403. PubMed ID: 17674351
[TBL] [Abstract][Full Text] [Related]
4. Phase II trial of mirtazapine for cancer-related cachexia and anorexia.
Riechelmann RP; Burman D; Tannock IF; Rodin G; Zimmermann C
Am J Hosp Palliat Care; 2010 Mar; 27(2):106-10. PubMed ID: 19776373
[TBL] [Abstract][Full Text] [Related]
5. Defining and classifying cancer cachexia: a proposal by the SCRINIO Working Group.
Bozzetti F; Mariani L
JPEN J Parenter Enteral Nutr; 2009; 33(4):361-7. PubMed ID: 19109514
[TBL] [Abstract][Full Text] [Related]
6. Risk factors relating blood markers of inflammation and nutritional status to survival in cachectic geriatric patients in a randomized clinical trial.
Yeh SS; Hafner A; Chang CK; Levine DM; Parker TS; Schuster MW
J Am Geriatr Soc; 2004 Oct; 52(10):1708-12. PubMed ID: 15450049
[TBL] [Abstract][Full Text] [Related]
7. Anorexia in chronic obstructive pulmonary disease--association to cachexia and hormonal derangement.
Koehler F; Doehner W; Hoernig S; Witt C; Anker SD; John M
Int J Cardiol; 2007 Jun; 119(1):83-9. PubMed ID: 17064790
[TBL] [Abstract][Full Text] [Related]
8. Double-blind, placebo-controlled, randomized study of eicosapentaenoic acid diester in patients with cancer cachexia.
Fearon KC; Barber MD; Moses AG; Ahmedzai SH; Taylor GS; Tisdale MJ; Murray GD
J Clin Oncol; 2006 Jul; 24(21):3401-7. PubMed ID: 16849754
[TBL] [Abstract][Full Text] [Related]
9. Palliative treatment of cancer anorexia with oral suspension of megestrol acetate.
Tomíska M; Tomisková M; Salajka F; Adam Z; Vorlícek J
Neoplasma; 2003; 50(3):227-33. PubMed ID: 12937858
[TBL] [Abstract][Full Text] [Related]
10. [Recent development in research and management of cancer anorexia-cachexia syndrome].
Inui A
Gan To Kagaku Ryoho; 2005 Jun; 32(6):743-9. PubMed ID: 15984510
[TBL] [Abstract][Full Text] [Related]
11. A phase II study of an herbal decoction that includes Astragali radix for cancer-associated anorexia in patients with advanced cancer.
Lee JJ; Lee JJ
Integr Cancer Ther; 2010 Mar; 9(1):24-31. PubMed ID: 20150220
[TBL] [Abstract][Full Text] [Related]
12. Combining ondansetron and naltrexone effectively treats biologically predisposed alcoholics: from hypotheses to preliminary clinical evidence.
Johnson BA; Ait-Daoud N; Prihoda TJ
Alcohol Clin Exp Res; 2000 May; 24(5):737-42. PubMed ID: 10832917
[TBL] [Abstract][Full Text] [Related]
13. Psychosocial issues in the diagnosis and management of cancer cachexia and anorexia.
Lesko LM
Nutrition; 1989; 5(2):114-6. PubMed ID: 2520268
[TBL] [Abstract][Full Text] [Related]
14. A retrospective study of the association between megestrol acetate administration and mortality among nursing home residents with clinically significant weight loss.
Bodenner D; Spencer T; Riggs AT; Redman C; Strunk B; Hughes T
Am J Geriatr Pharmacother; 2007 Jun; 5(2):137-46. PubMed ID: 17719516
[TBL] [Abstract][Full Text] [Related]
15. Therapy insight: Cancer anorexia-cachexia syndrome--when all you can eat is yourself.
Laviano A; Meguid MM; Inui A; Muscaritoli M; Rossi-Fanelli F
Nat Clin Pract Oncol; 2005 Mar; 2(3):158-65. PubMed ID: 16264909
[TBL] [Abstract][Full Text] [Related]
16. Randomized phase III clinical trial of five different arms of treatment for patients with cancer cachexia: interim results.
Mantovani G; Macciò A; Madeddu C; Gramignano G; Serpe R; Massa E; Dessì M; Tanca FM; Sanna E; Deiana L; Panzone F; Contu P; Floris C
Nutrition; 2008 Apr; 24(4):305-13. PubMed ID: 18262758
[TBL] [Abstract][Full Text] [Related]
17. Phase II study of high-dose fish oil capsules for patients with cancer-related cachexia.
Burns CP; Halabi S; Clamon G; Kaplan E; Hohl RJ; Atkins JN; Schwartz MA; Wagner BA; Paskett E
Cancer; 2004 Jul; 101(2):370-8. PubMed ID: 15241836
[TBL] [Abstract][Full Text] [Related]
18. Evaluation of nutritional status and dietary intake in patients with advanced cancer on palliative care.
Bovio G; Bettaglio R; Bonetti G; Miotti D; Verni P
Minerva Gastroenterol Dietol; 2008 Sep; 54(3):243-50. PubMed ID: 18614973
[TBL] [Abstract][Full Text] [Related]
19. The cancer anorexia-cachexia syndrome.
Nelson KA
Semin Oncol; 2000 Feb; 27(1):64-8. PubMed ID: 10697022
[TBL] [Abstract][Full Text] [Related]
20. Quantifying the impact of standardized assessment and symptom management tools on symptoms associated with cancer-induced anorexia cachexia syndrome.
Andrew IM; Waterfield K; Hildreth AJ; Kirkpatrick G; Hawkins C
Palliat Med; 2009 Dec; 23(8):680-8. PubMed ID: 19797339
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
